Please read the Legal Notice for further details.įreeStyle, Libre and related brand marks are trademarks of Abbott Diabetes Care Inc. Always read the label and use as directed.įor more information call Customer Service on 1 8 or +65 3138 3799. Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings. Getting real-time readings from your sensor can help you make quicker decisions, like eating a snack to treat a low blood sugar or g oing for a walk to bring down a high.The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. Using the FreeStyle Libre 2 with the mobile app can make living with diabetes a bit easier. New data will be collected and shown on your new phone, and all of the data from your old phone will only be visible on the desktop app, LibreView. If you do purchase a new phone that is compatible with your sensor, adding the mobile app will not carry over your old data. You can always turn off automatic updates and adjust your phone’s settings to not include the mobile app in upgrades. If your phone does a software upgrade, the FSL 2 mobile app may show a pop-up notification indicating any compatibility errors. Android and Apple phones perform maintenance software upgrades regularly that can impact how your sensor connects with your phone. Your phone may be compatible now, but that could change if your phone does a software upgrade. If it’s not, you’ll need to rely on the hand-held receiver instead. If you are purchasing a new phone, check to make sure it is compatible with your sensor. The FSL 2 sensor uses Bluetooth technology to connect to your phone, but that means your phone needs to have a specific operating system for that connection to work. Not All Smartphones Are SmartĮven though you may have a phone that is technically a “smartphone”, it still may not be compatible with the FreeStyle Libre 2 sensor. It also replaces the need to purchase a hand-held CGM receiver, eliminating another cost burden.Īlthough using a smartphone can make tracking your blood sugar levels more convenient, there are some hurdles that you may have to overcome to use a CGM mobile app. Most people already have their phones on them at all times, so using the mobile app just makes sense. Carrying around a diabetes “diaper bag” of supplies is just one more thing to add to the list!īy using your CGM’s mobile app, you can ease the burden of tracking your blood sugar levels throughout the day by reducing the amount of supplies you carry around. Whether you’re still learning the ropes or have been managing diabetes for years, living with diabetes can be a handful. The mobile app is available for Android and Apple phones. You can also send your FSL 2 readings directly to your phone and view your data in real-time! The FreeStyle Libre 2 CGM can be worn on the back of your arm or torso and sends your blood sugar readings to a hand-held monitor in real-time with a quick scan. Abbott’s Freestyle Libre 2 (FSL 2) is one of the CGMs on the market that offers this feature! CGMs are now even easier to use because you can pair them directly with a compatible smartphone, putting diabetes management in the palm of your hand. A CGM is a small wearable medical device that only needs to be applied once in a 10 to 14-day period (depending on the device) and can measure blood sugar levels continuously throughout the period of wear. Editorial control rests solely on Beyond Type 2.ĭiabetes management has become easier with the use of medical technology like i nsulin pumps and continuous glucose monitors (CGM). Educational content related to CGM use is made possible with support from Abbott Laboratories, an active partner of Beyond Type 1 at the time of publication.
0 Comments
Leave a Reply. |